Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

Agonism and Antagonism: Quantification

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

Passive Diffusion: Overview and Kinetics

Passive Diffusion: Overview and Kinetics

Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting their diffusion into...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Surface substance loss of subsurface bovine enamel lesions after different steps of the resinous infiltration technique: a 3D topography analysis.

Odontology·2011

Same author

Expression of IL-23/Th17 pathway in a murine model of Coxsackie virus B3-induced viral myocarditis.

Virology journal·2011

Same author

Extracellular matrix peptides of Artemia cyst shell participate in protecting encysted embryos from extreme environments.

PloS one·2011

Same author

Therapeutic effect of carboxymethylated and quanternized chitosan on insulin resistance in high-fat-diet-induced rats and 3T3-L1 adipocytes.

Journal of biomaterials science. Polymer edition·2011

Same author

Role of reactive oxygen species in triptolide-induced apoptosis of renal tubular cells and renal injury in rats.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban·2011

Same author

Chlorination and ortho-acetoxylation of 2-arylbenzoxazoles.

Organic & biomolecular chemistry·2011

Search research articles

Related Experiment Video

Updated: May 25, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Asymmetric drug-drug interaction prediction based on diffusion-augmented graph attention network.

Lei Zhang¹, Fan Yang², Jie Xia³

¹School of Computer and Information Engineering, Xiamen University of Technology, Xiamen, Fujian Province, 361024, China.

Neural Networks : the Official Journal of the International Neural Network Society

|May 23, 2026

Summary

Predicting drug-drug interactions (DDIs) is vital for patient safety. A new method, DiffGAT-DDI, uses graph attention and diffusion models to accurately capture asymmetric DDI information, improving prediction accuracy.

Keywords:

Asymmetry Attention Diffusion model Drug-drug interactions Dual-view learning

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

Related Experiment Videos

Last Updated: May 25, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

Area of Science:

Pharmacology and Cheminformatics
Artificial Intelligence in Medicine
Computational Drug Discovery

Background:

Accurate prediction of Drug-Drug Interactions (DDIs) is essential for minimizing adverse drug events.
Existing DDI prediction models struggle to capture the inherent asymmetry in drug interactions, leading to suboptimal performance.
The asymmetric nature of DDIs means that drug A interacting with drug B may not be the same as drug B interacting with drug A.

Purpose of the Study:

To develop a novel framework, Diffusion Graph Attention DDI (DiffGAT-DDI), for enhanced DDI prediction.
To effectively capture and leverage the asymmetric information present in drug-drug interactions.
To improve the accuracy and reliability of DDI prediction models.

Main Methods:

Utilized Morgan Fingerprints from drug molecular structures to create a directed DDI network.
Employed an extended bidirectional graph attention network with attention mechanisms for dual-view drug interaction representation learning.
Introduced an asymmetry-aware diffusion model incorporating edge structural noise and reverse diffusion processes.

Main Results:

DiffGAT-DDI significantly outperformed existing state-of-the-art models in both direction-specific and direction-agnostic DDI prediction tasks.
Achieved high performance metrics: 99.2% AUROC (Area Under the Receiver Operating Characteristic Curve) and 99.1% AUPRC (Area Under the Precision-Recall Curve).
Demonstrated substantial improvements over the best baseline, with a 2.1% increase in AUROC and a 4.0% increase in AUPRC.

Conclusions:

The proposed DiffGAT-DDI framework effectively captures complex asymmetric DDI patterns, leading to superior prediction accuracy.
This novel approach enhances model interpretability through attention mechanisms and improves upon current DDI prediction capabilities.
DiffGAT-DDI offers a promising advancement for safer polypharmacy and reduced risk of adverse drug events.